CIK 0001226616 · Non-accelerated filer<br>Smaller reporting company
MEDICINOVA INC
Sign in to watch- Ticker
- MNOV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330927979
- Phone
- 858-373-1500
- Business address
- 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,728,000
- in 1 filing
Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | 3D Investment Partners Pte. Ltd. Formerly 10% Owner | Sale | −640,000 | $2.70 | $1.7M | 4,862,047 |
| 2026-06-23 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +44,500 | 44,500 | ||
| 2026-06-23 | Lemerond Nicole Director | Grant or award · Stock Option (Right to Buy) | +44,500 | 44,500 | ||
| 2026-06-23 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +44,500 | 44,500 | ||
| 2026-01-16 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2026-01-16 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2025-06-17 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-06-17 | Lemerond Nicole Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-06-17 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-02-12 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +24,500 | 24,500 | ||
| 2025-02-12 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-02-12 | Lemerond Nicole Director | Grant or award · Stock Option (Right to Buy) | +24,500 | 24,500 | ||
| 2025-02-12 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-02-12 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +24,500 | 24,500 | ||
| 2025-01-07 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2025-01-07 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-06-11 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-06-11 | Lemerond Nicole Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-06-11 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2024-01-09 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +84,000 | 84,000 |
Page 1 of 8 · 149 trades